Q1 2021
Read transcript →Marker Therapeutics, Inc. (MRKR)
NASDAQ·Healthcare·Biotechnology
$1.43
-1.38%
Mkt Cap $15.87M
Q3 2020
Read transcript →Q1 2020
Read transcript →Q3 2019
Read transcript →Q4 2017
Read transcript →Q3 2017
Read transcript →Q2 2017
Read transcript →Q1 2017
Read transcript →Q4 2016
Read transcript →